Sinopharma Sinopharm has expanded its business scale
Sinopharm is a core enterprise of China National Pharmaceutical Group Corporation (ranked 199th in the Fortune 500), founded in January 2003 and listed in Hong Kong (01099.HK) in September 2009. Over the past ten years since its establishment, Sinopharm has expanded its business scale, improved its operation quality and grown its profitability. It has developed into a leading distributor and retailer of pharmaceuticals and healthcare products in China and a leading supply chain service provider, forming an integrated industrial chain with the synergistic development of distribution, retail treatment, chemical reagents, medical devices and healthcare services in the pharmaceutical and healthcare sectors.
2022 Informatization of China's Rehabilitation Industry
The rehabilitation industry caught the attention of the Chinese government again in 2021, and the industry entered a phase of accelerated development. The rehabilitation industry will first supplement medical resources and continue to explore a rehabilitation model that suits China's actual conditions. Under this context, EqualOcean Intelligence, together with Neusoft Group, released the 2022 Research Report On the Informatization of China's Rehabilitation Industry.
Sep 01, 2022 10:11 AM
ResearchTechnology, Healthcare, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchHealthcare, Real Estate, Industrials
Tech for Global, Globalization Footprints of the Established and the New
Ubrigene Bags Hundreds of Mns of CNY in Series C Financing Round
Ubrigene, dedicated to providing one-stop CDMO services for cell and gene therapies, will continue to improve its management system and incubate more specialized technology platforms with the fresh proceeds.
Sep 27, 2022 06:35 PM
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM